Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Chronic Heart Failure

  Free Subscription


12.10.2026

1 Am Heart J
1 Am J Cardiol
2 Chest
1 Circ Arrhythm Electrophysiol
1 Circulation
2 Clin Cardiol
4 Eur Heart J
5 Eur J Heart Fail
1 Heart
1 Int J Cardiol
1 J Am Coll Cardiol
2 J Card Fail
1 J Cardiol
1 J Mol Cell Cardiol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. LURIE A, Daneii P, Sze CH, Khanani A, et al
    Design and rationale of the Urine Sodium-directed Diuretic Adjustment Strategy in Heart Failure (US-DASH) trial.
    Am Heart J. 2026 Oct 6:107622. doi: 10.1016/j.ahj.2026.107622.
    PubMed         Abstract available


    Am J Cardiol

  2. QURESHI S, Sajid M, Khan HR, Greene SJ, et al
    Association between Socioeconomic Deprivation and Clinical Outcomes of Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure.
    Am J Cardiol. 2026 Oct 9:S0002-9149(26)00619.
    PubMed         Abstract available


    Chest

  3. MOLINGER J, Fudim M
    The Respiratory Muscles in Heart Failure With Preserved Ejection Fraction: A Hidden Tax on Exercise Tolerance.
    Chest. 2026;170:998-1000.
    PubMed        

  4. SULICA R, De Marco T, Elwing JM, Bartolome S, et al
    Managing a Critically Ill Patient With Pulmonary Arterial Hypertension.
    Chest. 2026;170:1260-1271.
    PubMed         Abstract available


    Circ Arrhythm Electrophysiol

  5. AFZALIAN A, Oraii A, Chaumont C, Rodriguez-Queralto O, et al
    Value of Left Ventricular Low Voltage Area and Ejection Fraction in Predicting End-Stage Heart Failure Outcomes After Ventricular Tachycardia Ablation in Patients With Non-Ischemic Cardiomyopathy.
    Circ Arrhythm Electrophysiol. 2026 Oct 8:e014886. doi: 10.1161/CIRCEP.126.014886
    PubMed         Abstract available


    Circulation

  6. KOMURO J, Ko T, Ito M, Hashimoto H, et al
    Mast Cell-Derived IL-4 Induces Pathogenic Cardiac Fibroblasts in Heart Failure.
    Circulation. 2026;154:1378-1381.
    PubMed        


    Clin Cardiol

  7. AVERBUCH T, Miller RJH, Ezekowitz J, Howlett JG, et al
    Prognostic Significance and Factors Associated With Worsening LV Dilatation in Heart Failure.
    Clin Cardiol. 2026;49:e70490.
    PubMed         Abstract available

  8. KHAN A, Shabbir MR, Nasrallah J, Imtiaz M, et al
    Association of RSV Vaccination With Clinical Outcomes in Older Adults With Heart Failure: A Propensity-Matched Analysis.
    Clin Cardiol. 2026;49:e70488.
    PubMed         Abstract available


    Eur Heart J

  9. LAOUTARIS ID, Dritsas A, Adamopoulos S
    Training the diaphragm as a pillar of cardiac rehabilitation in heart failure.
    Eur Heart J. 2026 Oct 5:ehag789. doi: 10.1093.
    PubMed        

  10. ELBATREEK MH, Li Z, Yu X, Gehred ND, et al
    Semaglutide, independent of weight loss, attenuates cardiac and hepatic remodelling in experimental heart failure with preserved ejection fraction.
    Eur Heart J. 2026 Oct 5:ehag732. doi: 10.1093.
    PubMed         Abstract available

  11. ZIZEK D, Ivanovski M, Mrak M, Pestrea C, et al
    Biventricular vs conduction system pacing after atrioventricular node ablation for heart failure with atrial fibrillation: the CONDUCT-AF trial.
    Eur Heart J. 2026 Oct 6:ehag699. doi: 10.1093.
    PubMed         Abstract available

  12. YALCIN GD, Meder B
    The power of proteomics: predicting mortality in heart failure.
    Eur Heart J. 2026 Oct 8:ehag721. doi: 10.1093.
    PubMed        


    Eur J Heart Fail

  13. KOBAYASHI M, Duarte K, Baudry G, Ferreira JP, et al
    Kidney function decline, heart failure hospitalization, and the effect of empagliflozin in heart failure: an EMPEROR-pooled analysis.
    Eur J Heart Fail. 2026 Oct 6:xuag295. doi: 10.1093.
    PubMed         Abstract available

  14. TORRELLES A, Domingo M, Zamora E, Lupon J, et al
    SAFE-EXIT HF Study: Integrating Ultrasound Congestion Assessment with Clinical Variables to Predict Outcomes After Heart Failure Hospitalization.
    Eur J Heart Fail. 2026 Oct 6:xuag300. doi: 10.1093.
    PubMed        

  15. BAUDRY G
    Revisiting dry weight in heart failure: a treatment-defined target in the era of foundational medical therapy?
    Eur J Heart Fail. 2026 Oct 6:xuag304. doi: 10.1093.
    PubMed        


  16. Correction to: Implementation of guideline-directed medical therapy in patients with heart failure and obesity: European Journal of Heart Failure expert consensus document.
    Eur J Heart Fail. 2026 Oct 8:xuag264. doi: 10.1093.
    PubMed        

  17. BIEGUS J, Davison B, Cotter G, Edwards C, et al
    GDMT is Associated with Reduced Loop Diuretic Requirements, Whereas Diuretic Dose Does Not Modify GDMT Benefit in Heart Failure: STRONG-HF.
    Eur J Heart Fail. 2026 Oct 9:xuag309. doi: 10.1093.
    PubMed         Abstract available


    Heart

  18. CHRISTENSEN MK, Pedersen AK, Hyldgard VB, Moller JE, et al
    Timing of heart failure diagnosis and uptake of newly recommended therapies following clinical guideline updates.
    Heart. 2026 Oct 8:heartjnl-2025-327578. doi: 10.1136/heartjnl-2025-327578.
    PubMed        


    Int J Cardiol

  19. CASTIGLIONE V, Aimo A, Vergaro G
    High-sensitivity troponin T to suspect transthyretin amyloidosis in acute heart failure: is hospital admission the right time?
    Int J Cardiol. 2026 Oct 8:134976. doi: 10.1016/j.ijcard.2026.134976.
    PubMed        


    J Am Coll Cardiol

  20. LALANI C, Butala N, Dong H, Song Y, et al
    Estimating the Effects of MTEER in U.S. Practice: A Transportability Analysis of the COAPT Trial.
    J Am Coll Cardiol. 2026;88:1704-1716.
    PubMed         Abstract available


    J Card Fail

  21. PACKER M, Butler J, Zannad F, Vaduganathan M, et al
    The Comorbidity-Driven Interleukin-6-Mediated Systemic Inflammation Hypothesis of Heart Failure With Preserved Ejection Fraction: A Decade of Testing Ends in Disappointment.
    J Card Fail. 2026 Oct 5:S1071-9164(26)00594.
    PubMed         Abstract available

  22. GORODESKI EZ, Fonarow GC, Goyal P, Ahmad FS, et al
    HF STATS 2026: An Updated Report on Heart Failure Epidemiology and Outcomes from the Heart Failure Society of America.
    J Card Fail. 2026 Oct 5:S1071-9164(26)00406.
    PubMed        


    J Cardiol

  23. KUBOTA Y, Tanaka H, Fujimoto W, Yokota H, et al
    Impact of dementia and its progression on mortality in heart failure with preserved ejection fraction -insight from the KUNIUMI registry chronic cohort.
    J Cardiol. 2026 Oct 7:S0914-5087(26)00192-9. doi: 10.1016/j.jjcc.2026.
    PubMed         Abstract available


    J Mol Cell Cardiol

  24. IQBAL Z, Fiegle D, Minabari G, Heim C, et al
    A transmural t-tubule gradient in the human left ventricle is lost in heart failure: implications for myocardial biopsy assessment.
    J Mol Cell Cardiol. 2026 Oct 9:S0022-2828(26)00158.
    PubMed         Abstract available


    PLoS One

  25. GOWANI A, Norris C, Low G, Ajani K, et al
    Translation and cultural adaptation of the Minnesota Living with Heart Failure Questionnaire for use in Pakistan.
    PLoS One. 2026;21:e0360245.
    PubMed         Abstract available

  26. HAKANSSON E, Anan I, Brunstrom M, Hellstrom-Angerud K, et al
    Using dapagliflozin to reduce symptoms in transthyretin cardiac amyloidosis: An n-of-1 trial series pilot study.
    PLoS One. 2026;21:e0346065.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum